Drug Profile
AvidinOx-Lu-177-DOTA - Biotin
Alternative Names: 177Lu-ST2210; AvidinOX®; Oxidised Avidin - sigma-tau; ST2210Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator sigma-tau SpA
- Class Antineoplastics; Glycoproteins; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver metastases; Lymphoma; Solid tumours
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for phase-I development in Lymphoma(Inoperable/Unresectable) in USA (Intralesional, Injection)
- 28 Jul 2020 No recent reports of development identified for phase-I development in Lymphoma(Inoperable/Unresectable) in USA (IV, Injection)
- 28 Jul 2020 No recent reports of development identified for phase-I development in Solid-tumours(Inoperable/Unresectable) in USA (Intralesional, Injection)